Rare diseases
Investigational molecules
Locations
Study on the Safety and Effects of Relatlimab and Nivolumab for Patients with Advanced Solid Tumors
FinlandStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
FinlandStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
FinlandStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
FinlandStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
FinlandStudy on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease
FinlandStudy on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB
FinlandStudy of Belzutifan with Lenvatinib versus Cabozantinib in Adults with Advanced Renal Cell Carcinoma Who Have Previously Received Anti-PD-1/L1 Treatment
FinlandStudy on the Effects of KAN-101 and Sodium Chloride in Adults with Celiac Disease
FinlandStudy on Crizanlizumab for Adolescents and Adults with Sickle Cell Disease Experiencing Vaso-Occlusive Crises
FinlandStudy of Pembrolizumab, Vibostolimab, and Belzutifan for Patients with Metastatic Castration-Resistant Prostate Cancer
FinlandStudy of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
